Saturn V Capital Management LLC Sage Therapeutics, Inc. Transaction History

Saturn V Capital Management LLC

3 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2023 Aug 14, 2023	SELL	$40.65 - $59.54 $3.03 Million - $4.43 Million	-74,459 Reduced 51.34%	70,559 $3.32 Billion
Q1 2023 May 15, 2023	SELL	$37.27 - $46.57 $412,467 - $515,390	-11,067 Reduced 7.09%	145,018 $6.08 Billion
Q4 2022 Feb 09, 2023	BUY	$32.2 - $43.61 $5.03 Million - $6.81 Million	156,085 New	156,085 $5.37 Billion

198

46.5M

402K

209K

Ticker SAGE
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 59,422,300
Market Cap $323M
Description
Sage Therapeutics, Inc., a biopharmaceutical company, develops and commercializes medicines to treat central nervous system disorders. Its lead product candidate is ZULRESSO, an intravenous formulation of brexanolone for the treatment of postpartum depression (PPD) in adults. The company's product pipeline also includes zuranolone, a neuroactive...

Get notified when there are updates to the investment portfolio of Saturn V Capital Management LLC, based on Form 13F filings with the SEC.

Stay updated on Saturn V Capital Management LLC with notifications on news.